Table of Contents

Evolution of Sleep Apnea Oral Appliances Market

Sleep apnea oral appliances market is expected to reach USD 0.9 billion by 2028 from USD 0.4 billion in 2023, at a CAGR of 15.2%
Sleep apnea oral appliances market

According to a new report by MarketsandMarkets – Sleep Apnea Oral Appliances Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $0.9 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028. The growth of this market is majorly driven by the high risk of growing awarrness and diagnosis of sleep apnea among patients and healthcare professionals. Furthermore, the poor compliance associated with CPAP is expected to drive the growth of the sleep apnea oral appliances market.

Download an Illustrative overview:

Mandibular advancement devices force the lower jaw forward and downwards slightly, which keeps the airway open. The device helps treat OSA by offering maximum anterior tongue space along with the retention of teeth movement. This segment is expected to dominate the global sleep apnea oral appliances market during the forecast period, driven by a rising patient preference for non-CPAP solutions due comfort and ease of use.

By end user, the global sleep apnea oral appliances market is broadly segmented into home care settings/individuals, hospitals, and dental clinics. The large share of this segment can be attributed to factors such as the increasing number of sleep centers globally, the rise of number of sleep care devices for homecare settings offered by leading players.

Based on the region, the sleep apnea oral appliances market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North American market is driven by high prevalence and diagnosis of sleep apnea in the region. Europe is the second-largest market for the sleep apnea oral appliances market due to the growing aging population in the region. Asia Pacific will observe high growth during the forecast period with its growing healthcare expenditure with improving accessibility to sleep clinics and treatment for sleep apnea in the region’s countries.

Request Sample Pages:

Sleep Apnea Oral Appliances Market Dynamics:


  1. Large pool of undiagnosed sleep apnea patients


  1. Associated risks of oral appliances for obstructive sleep apnea treatment


  1. Poor compliance associated with CPAP


  1. Expenses associated with customization of oral appliances

Key Market Players of Sleep Apnea Oral Appliances Industry:

Major players in the sleep apnea oral appliances market include SonmoMed (Australia), resMed (US), Whole You, Inc. (US), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US).

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (40%), Tier 2 (50%), and Tier 3 (10%)
  • By Designation: C-level (48%), Director-level (37%), and Others (15%)
  • By Region: North America (56%), Europe (20%), Asia- Pacific (17%), and Rest of the World (7%)

Sleep Apnea Oral Appliances Market Recent Developments:

  • In 2023, Vivos Therapeutics, Inc. (US) DNA appliance was granted 510(k) clearance from the U.S. Food & Drug Administration (or FDA) as a Class II medical device in December 2022 for the treatment of snoring and mild to moderate OSA in adults.
  • In 2022, ResMed (US) acquired the German-based clinical, financial, and operational solutions provider MEDIFOX DAN (Germany) to drive leadership in out-of-hospital software solutions.
  • In 2021, SomoMed (Australia) conducted SomSUMMIT ’21, which aimed to enhance research, education, and awareness of oral appliance therapy as a primary solution to successful OSA treatment.
Blog Tags
Blog Category

Leave a Reply